0001032220FALSE00010322202024-08-072024-08-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 7, 2024
maximus-logo.jpg

Maximus, Inc.
(Exact name of registrant as specified in its charter)
Virginia1-1299754-1000588
(State or other jurisdiction of incorporation)
 (Commission File Number)
(I.R.S. Employer Identification No.)
1600 Tysons BoulevardMcLean,VA22102
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including the area code(703)251-8500
No Change
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, no par valueMMSNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02    Results of Operations and Financial Condition.
 
On August 7, 2024, the Company issued a press release announcing its financial results for the quarter ended June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report.

The information contained in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


Item 9.01    Financial Statements and Exhibits.

(d)     Exhibits.
  
Exhibit No.Description
  
Press release dated August 7, 2024
104Inline XBRL for the cover page of this Current Report on Form 8-K.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Maximus, Inc.
(Registrant)
Date: August 7, 2024/s/ John T. Martinez
John T. Martinez
General Counsel and Secretary



2
maximus_logox2022xmed002.jpg
FOR IMMEDIATE RELEASECONTACT:James Francis, VP - IR
Jessica Batt, VP - IR & ESG
Date: August 7, 2024IR@maximus.com

Maximus Reports Fiscal Year 2024 Third Quarter Results
Favorable tailwinds persist and drive third consecutive raise to FY24 guidance
(Tysons, Va. - August 7, 2024) - Maximus (NYSE: MMS), a leading provider of government services worldwide, reported financial results for the three and nine months ending June 30, 2024.
Highlights for the third quarter of fiscal year 2024 include:
•Revenue increased 10.6% to $1.31 billion, compared to $1.19 billion for the prior year period. All three segments contributed to organic growth of 11.2%, with the U.S. Federal Services Segment being the primary driver.
•Diluted earnings per share were $1.46 and adjusted diluted earnings per share were $1.74, compared to $0.50 and $0.78, respectively, for the prior year period.
•Guidance is increasing again for fiscal year 2024. At the midpoints, revenue is increasing by $100 million, adjusted operating income guidance is increasing by $30 million, adjusted diluted earnings per share by $0.35, and free cash flow by $15 million.
•Net debt to EBITDA ratio improved to 1.5 times at June 30, 2024, compared to 1.7 times in the prior quarter.
•A quarterly cash dividend of $0.30 per share is payable on August 31, 2024, to shareholders of record on August 15, 2024.
"Our third quarter demonstrates our ability to capitalize on favorable tailwinds that have persisted across this year, where we accomplished high quality and efficient delivery, at scale," said Bruce Caswell, President and Chief Executive Officer. "I want to acknowledge and thank all our teams for their respective roles in delivering exceptional performance this quarter, enabling us to solidly beat expectations and continue the momentum of the business this year."

Third Quarter Results
Revenue for the third quarter of fiscal year 2024 increased 10.6% to $1.31 billion, compared to $1.19 billion for the prior year period. All three segments contributed to consolidated organic growth of 11.2%, with the primary driver being volume growth on clinical programs in the U.S. Federal Services Segment.
For the third quarter of fiscal year 2024, operating margin was 10.8% and the adjusted operating margin was 12.6%. This compares to margins of 4.9% and 6.9%, respectively, for the prior year period. Diluted earnings per share were $1.46 and adjusted diluted earnings per share were $1.74. This compares to $0.50 and $0.78, respectively, for the prior year period which included a $0.26 impact from the previously disclosed cybersecurity incident. Exceptional performance within environments of strong demand across both domestic segments led to higher-than-anticipated earnings this quarter.
U.S. Federal Services Segment
U.S. Federal Services Segment revenue for the third quarter of fiscal year 2024 increased 17.0% to $683.3 million, compared to $584.0 million reported for the prior year period. All growth was organic and driven primarily by volume growth on clinical programs.
The segment operating margin for the third quarter of fiscal year 2024 was 15.5%, compared to 12.7% reported for the prior year period. This quarter's margin reflects excellent operational execution combined with high demand for services, particularly in clinical services, and a temporarily favorable mix of lower cost-plus revenue and higher performance-based revenue. The full-year fiscal 2024 margin for the U.S. Federal Services Segment is now expected to be approximately 12.5%.

1
maximus_logox2022xmed002.jpg

U.S. Services Segment
U.S. Services Segment revenue for the third quarter of fiscal year 2024 increased 5.2% to $472.3 million, compared to $449.1 million reported in the prior year period. All growth was organic and enabled by strong performance across the Medicaid-related portfolio, a portion of which were excess volumes from the unwinding exercise which is now completed.
The segment operating margin for the third quarter of fiscal year 2024 was 13.0%, compared to 10.5% reported for the prior year. This quarter's margin benefited from the strong Medicaid-related performance and the aforementioned excess volumes. The full-year fiscal 2024 margin for the U.S. Services Segment is anticipated to be approximately 13%.
Outside the U.S. Segment
Outside the U.S. Segment revenue for the third quarter of fiscal year 2024 increased 2.3% to $159.3 million, compared to $155.7 million reported in the prior year period. Organic growth was 6.8% and driven primarily by strong operations in the United Kingdom, with the effect of divested businesses partially offsetting the growth.
The segment realized an operating loss of $1.4 million for the third quarter of fiscal year 2024, compared to a loss of $15.2 million in the prior year period. This quarter's loss was contemplated in the full-year outlook for the segment, which remains slightly above breakeven. A smaller footprint and improved profitability are expected once segment-shaping efforts are complete, which remain a priority for this fiscal year.
Sales and Pipeline
Year-to-date signed contract awards at June 30, 2024, totaled $1.25 billion, and contracts pending (awarded but unsigned) totaled $398 million. The book-to-bill ratio at June 30, 2024, was 0.6x calculated on a trailing twelve-month basis.
The sales pipeline at June 30, 2024, totaled $44.1 billion, comprised of approximately $2.93 billion in proposals pending, $7.33 billion in proposals in preparation, and $33.8 billion in opportunities tracking. This quarter's large increase to the pipeline is attributable to capturing the Contact Center Operations (CCO) early recompete and the Veterans Affairs Medical Disability Examination contracts recompete stemming from higher volumes on the program. New work opportunities represent approximately 55% of the total sales pipeline.
Balance Sheet and Cash Flows
At June 30, 2024, cash and cash equivalents totaled $103 million, and gross debt was $1.16 billion. The ratio of debt, net of allowed cash, to EBITDA for the quarter ended June 30, 2024, as calculated in accordance with our credit agreement, was 1.5x. This compares to 1.7x at March 31, 2024.
For the third quarter of fiscal year 2024, cash provided by operating activities totaled $199 million, and free cash flow was $165 million. DSO at June 30, 2024, were 59 days, compared with 62 days at March 31, 2024.
During the third quarter of fiscal year 2024, we purchased approximately 611,000 shares, totaling $50.6 million, which is an average price of $82.79 per share. Subsequent to June 30, 2024, we purchased an additional 250,000 shares, totaling $21.2 million, at an average price of $84.78 per share. In June 2024, the Board of Directors authorized an expansion to the purchase program for Maximus common stock of up to an aggregate of $200 million.
On July 5, 2024, our Board of Directors declared a quarterly cash dividend of $0.30 for each share of our common stock outstanding. The dividend is payable on August 31, 2024, to shareholders of record on August 15, 2024.
Further Raise to FY24 Guidance
Maximus is further raising fiscal year 2024 guidance following its third quarter results. Revenue is now expected to range between $5.25 billion and $5.35 billion, representing an increase of $100 million from the midpoint of prior guidance.
2
maximus_logox2022.jpg
Adjusted operating income is now expected to range between $570 million and $590 million, representing an increase of $30 million from the midpoint of prior guidance. Adjusted operating income excludes an estimated $90 million of expense for amortization of intangible assets and $1 million of divestiture-related charges.

Adjusted diluted earnings per share is now expected to range between $6.00 and $6.20 per share, representing an increase of $0.35 per share from the midpoint of prior guidance.
Free cash flow is now expected to range between $350 million and $380 million as a result of the increased earnings guidance and partially offset by higher capital expenditures for the remainder of the year. Interest expense is estimated to be $80 million for fiscal year 2024.
Conference Call and Webcast Information
Maximus will host a conference call tomorrow, August 8, 2024, at 9:00 a.m. ET. Shareholders are invited to submit questions for management’s consideration by emailing IR@maximus.com up to one hour prior to the call.
The call is open to the public and available by webcast or by phone at:
877.407.8289 (Domestic) / +1.201.689.8341 (International)
For those unable to listen to the live call, a recording of the webcast will be available on investor.maximus.com.
About Maximus
As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com.
Non-GAAP Measures and Forward-Looking Statements
This release contains non-GAAP measures and other indicators, including organic growth, free cash flow, operating income and EPS adjusted for amortization of intangible assets and divestiture-related charges, adjusted EBITDA, and other non-GAAP measures. A description of these non-GAAP measures and details as to how they are calculated are included with our earnings presentation and forthcoming Form 10-Q.
The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operations, revenue growth, operating income, or net income as measures of performance. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.
Statements that are not historical facts, including statements about our confidence and strategies, and our expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand, or acceptance of our products are forward-looking statements that involve risks and uncertainties.
These risks could cause our actual results to differ materially from those indicated by such forward-looking statements. A Special Note Regarding Forward-Looking Statements is included within our forthcoming Form 10-Q and a summary of risk factors can be found in Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended September 30, 2023, which was filed with the Securities and Exchange Commission (SEC) on November 16, 2023. Our SEC reports are accessible on maximus.com.

3
maximus_logox2022.jpg
Maximus, Inc.
Consolidated Statements of Operations
(Unaudited)

 For the Three Months EndedFor the Nine Months Ended
 June 30, 2024June 30, 2023June 30, 2024June 30, 2023
(in thousands, except per share amounts)
Revenue$1,314,929 $1,188,677 $3,990,327 $3,644,775 
Cost of revenue982,615 924,313 3,040,370 2,907,061 
Gross profit332,314 264,364 949,957 737,714 
Selling, general, and administrative expenses167,033 182,545 504,682 471,445 
Amortization of intangible assets23,542 23,431 68,532 70,599 
Operating income141,739 58,388 376,743 195,670 
Interest expense20,555 21,026 62,428 63,631 
Other expense/(income), net809 1,005 475 (79)
Income before income taxes120,375 36,357 313,840 132,118 
Provision for income taxes30,623 5,494 79,430 29,472 
Net income$89,752 $30,863 $234,410 $102,646 
Earnings per share:
Basic$1.47 $0.50 $3.83 $1.68 
Diluted$1.46 $0.50 $3.81 $1.67 
Weighted average shares outstanding:
Basic61,079 61,141 61,233 61,125 
Diluted61,381 61,544 61,495 61,368 
Dividends declared per share$0.30 $0.28 $0.90 $0.84 










4
maximus_logox2022.jpg
Maximus, Inc.
Consolidated Balance Sheets
June 30, 2024September 30, 2023
(unaudited)
(in thousands)
Assets:
Cash and cash equivalents$102,794 $65,405 
Accounts receivable, net850,462 826,873 
Income taxes receivable9,464 16,556 
Prepaid expenses and other current assets115,571 146,632 
Total current assets1,078,291 1,055,466 
Property and equipment, net35,020 38,831 
Capitalized software, net169,449 107,811 
Operating lease right-of-use assets138,817 163,929 
Goodwill1,780,299 1,779,215 
Intangible assets, net653,386 703,648 
Deferred contract costs, net53,899 45,372 
Deferred compensation plan assets52,895 42,919 
Deferred income taxes5,911 2,459 
Other assets31,823 46,147 
Total assets$3,999,790 $3,985,797 
Liabilities and Shareholders' Equity:
Liabilities:
Accounts payable and accrued liabilities$280,836 $282,081 
Accrued compensation and benefits162,318 194,251 
Deferred revenue, current portion82,065 60,477 
Income taxes payable11,146 451 
Long-term debt, current portion39,952 86,844 
Operating lease liabilities, current portion47,992 49,852 
Other current liabilities55,734 49,058 
Total current liabilities680,043 723,014 
Deferred revenue, non-current portion35,269 38,849 
Deferred income taxes200,814 203,898 
Long-term debt, non-current portion1,100,701 1,163,149 
Deferred compensation plan liabilities, non-current portion55,870 46,432 
Operating lease liabilities, non-current portion101,911 129,367 
Other liabilities6,467 13,253 
Total liabilities2,181,075 2,317,962 
Shareholders' equity:
Common stock, no par value; 100,000 shares authorized; 60,427 and 60,998 shares issued and outstanding as of June 30, 2024, and September 30, 2023, respectively604,287 577,898 
Accumulated other comprehensive loss(30,934)(27,615)
Retained earnings1,245,362 1,117,552 
Total shareholders' equity1,818,715 1,667,835 
Total liabilities and shareholders' equity$3,999,790 $3,985,797 
5
maximus_logox2022.jpg
Maximus, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
For the Three Months EndedFor the Nine Months Ended
June 30, 2024June 30, 2023June 30, 2024June 30, 2023
(in thousands)
Cash flows from operating activities:
Net income$89,752 $30,863 $234,410 $102,646 
Adjustments to reconcile net income to cash flows from operations:
Depreciation and amortization of property, equipment, and capitalized software7,530 10,771 24,146 37,092 
Amortization of intangible assets23,542 23,431 68,532 70,599 
Amortization of debt issuance costs and debt discount1,697 601 2,899 2,236 
Deferred income taxes4,545 3,743 (3,770)2,375 
Stock compensation expense9,481 8,296 27,605 22,239 
Loss on sale of businesses— — 1,018 883 
Change in assets and liabilities, net of effects of business combinations:
Accounts receivable65,857 (54,854)(26,528)7,675 
Prepaid expenses and other current assets(616)7,689 19,316 21,101 
Deferred contract costs(4,777)1,662 (8,377)2,245 
Accounts payable and accrued liabilities4,642 23,276 (1,659)16,915 
Accrued compensation and benefits(10,487)(17,390)(21,043)(31,612)
Deferred revenue7,374 (13,400)18,079 (31,747)
Income taxes(2,734)(26,608)10,576 (33,186)
Operating lease right-of-use assets and liabilities(1,746)(1,670)(2,131)(3,742)
Other assets and liabilities5,268 (1,696)8,351 (15,968)
Net cash provided by/(used in) operating activities199,328 (5,286)351,424 169,751 
Cash flows from investing activities:
Purchases of property and equipment and capitalized software(34,690)(25,112)(82,237)(58,863)
Asset acquisition— — (18,006)— 
Proceeds from divestitures— — 3,078 9,124 
Net cash used in investing activities(34,690)(25,112)(97,165)(49,739)
Cash flows from financing activities:
Cash dividends paid to Maximus shareholders(18,239)(17,020)(54,847)(51,053)
Purchases of Maximus common stock(47,275)— (47,275)— 
Tax withholding related to RSU vesting— — (13,455)(8,475)
Payments for contingent consideration(2,809)(2,621)(10,977)(6,662)
Payments for debt financing costs(9,724)— (9,724)— 
Proceeds from borrowings426,757 220,000 850,166 682,398 
Principal payments for debt(488,038)(200,054)(952,825)(730,514)
Cash-collateralized escrow liabilities3,996 2,517 9,118 (54,543)
Net cash provided by/(used in) financing activities(135,332)2,822 (229,819)(168,849)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash155 549 1,270 3,735 
Net change in cash, cash equivalents, and restricted cash29,461 (27,027)25,710 (45,102)
Cash, cash equivalents, and restricted cash, beginning of period118,340 118,720 122,091 136,795 
Cash, cash equivalents, and restricted cash, end of period$147,801 $91,693 $147,801 $91,693 
6
maximus_logox2022.jpg
Maximus, Inc.
Consolidated Results of Operations by Segment
(Unaudited)
 For the Three Months EndedFor the Nine Months Ended
June 30, 2024June 30, 2023June 30, 2024June 30, 2023
Amount% (1)Amount% (1)Amount% (1)Amount% (1)
(dollars in thousands)
Revenue:
U.S. Federal Services$683,347 $583,960 $2,062,127 $1,786,202 
U.S. Services472,298 449,061 1,448,258 1,338,242 
Outside the U.S.159,284 155,656 479,942 520,331 
Revenue$1,314,929 $1,188,677 $3,990,327 $3,644,775 
Gross profit:
U.S. Federal Services$186,075 27.2 %$156,945 26.9 %$506,074 24.5 %$402,513 22.5 %
U.S. Services121,012 25.6 %98,538 21.9 %369,497 25.5 %268,152 20.0 %
Outside the U.S.25,227 15.8 %8,881 5.7 %74,386 15.5 %67,049 12.9 %
Gross profit$332,314 25.3 %$264,364 22.2 %$949,957 23.8 %$737,714 20.2 %
Selling, general, and administrative expenses:
U.S. Federal Services$79,949 11.7 %$82,892 14.2 %$247,671 12.0 %$229,591 12.9 %
U.S. Services59,531 12.6 %51,536 11.5 %174,032 12.0 %140,793 10.5 %
Outside the U.S.26,647 16.7 %24,122 15.5 %75,249 15.7 %75,936 14.6 %
Divestiture-related charges (2)— NM— NM1,018 NM883 NM
Other (3)906 NM23,995 NM6,712 NM24,242 NM
Selling, general, and administrative expenses$167,033 12.7 %$182,545 15.4 %$504,682 12.6 %$471,445 12.9 %
Operating income/(loss):
U.S. Federal Services$106,126 15.5 %$74,053 12.7 %$258,403 12.5 %$172,922 9.7 %
U.S. Services61,481 13.0 %47,002 10.5 %195,465 13.5 %127,359 9.5 %
Outside the U.S.(1,420)(0.9)%(15,241)(9.8)%(863)(0.2)%(8,887)(1.7)%
Amortization of intangible assets(23,542)NM(23,431)NM(68,532)NM(70,599)NM
Divestiture-related charges (2)— NM— NM(1,018)NM(883)NM
Other (3)(906)NM(23,995)NM(6,712)NM(24,242)NM
Operating income$141,739 10.8 %$58,388 4.9 %$376,743 9.4 %$195,670 5.4 %
        
(1)Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM."
(2)We have sold businesses in both fiscal years 2023 and 2024.
(3)Other expenses includes credits and costs that are not allocated to a particular segment. In the three and nine months ended June 30, 2024, these charges include $0.3 million and $3.3 million related to the costs of a previously disclosed cybersecurity incident, respectively, compared to $22.1 million for the three and nine months ended June 30, 2023. Other charges include expenses incurred as part of our acquisitions, as well as potential acquisitions that have not been or may not be completed.
7
maximus_logox2022.jpg
Maximus, Inc.
Consolidated Free Cash Flows - Non-GAAP
(Unaudited)
For the Three Months EndedFor the Nine Months Ended
June 30, 2024June 30, 2023June 30, 2024June 30, 2023
(in thousands)
Net cash provided by/(used in) operating activities$199,328 $(5,286)$351,424 $169,751 
Purchases of property and equipment and capitalized software(34,690)(25,112)(82,237)(58,863)
Free cash flow (Non-GAAP)$164,638 $(30,398)$269,187 $110,888 


Maximus, Inc.
Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets and Divestiture-Related Charges
(Unaudited)
For the Three Months EndedFor the Nine Months Ended
June 30, 2024June 30, 2023June 30, 2024June 30, 2023
(dollars in thousands, except per share data)
Operating income$141,739 $58,388 $376,743 $195,670 
Add back: Amortization of intangible assets23,542 23,431 68,532 70,599 
Add back: Divestiture-related charges— — 1,018 883 
Adjusted operating income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP)$165,281 $81,819 $446,293 $267,152 
Adjusted operating income margin excluding amortization of intangible assets and divestiture-related charges (Non-GAAP)12.6 %6.9 %11.2 %7.3 %
Net income$89,752 $30,863 $234,410 $102,646 
Add back: Amortization of intangible assets, net of tax17,350 17,276 50,508 52,082 
Add back: Divestiture-related charges— — 1,018 883 
Adjusted net income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP)$107,102 $48,139 $285,936 $155,611 
Diluted earnings per share$1.46 $0.50 $3.81 $1.67 
Add back: Effect of amortization of intangible assets on diluted earnings per share0.28 0.28 0.82 0.86 
Add back: Effect of divestiture-related charges on diluted earnings per share— — 0.02 0.01 
Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture-related charges (Non-GAAP)$1.74 $0.78 $4.65 $2.54 
8
v3.24.2.u1
Cover Page
Aug. 07, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 07, 2024
Entity Registrant Name Maximus, Inc.
Entity Incorporation, State or Country Code VA
Entity File Number 1-12997
Entity Tax Identification Number 54-1000588
Entity Address, Address Line One 1600 Tysons Boulevard
Entity Address, City or Town McLean
Entity Address, State or Province VA
Entity Address, Postal Zip Code 22102
City Area Code 703
Local Phone Number 251-8500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, no par value
Trading Symbol MMS
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001032220
MAXIMUS (NYSE:MMS)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024 Haga Click aquí para más Gráficas MAXIMUS.
MAXIMUS (NYSE:MMS)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024 Haga Click aquí para más Gráficas MAXIMUS.